CAMOZZI, Maura
 Distribuzione geografica
Continente #
NA - Nord America 490
EU - Europa 425
AS - Asia 180
SA - Sud America 12
OC - Oceania 2
AF - Africa 1
Totale 1.110
Nazione #
US - Stati Uniti d'America 490
PL - Polonia 196
CN - Cina 78
UA - Ucraina 60
SG - Singapore 54
DE - Germania 48
ES - Italia 23
FI - Finlandia 23
HK - Hong Kong 23
GB - Regno Unito 19
IT - Italia 18
RU - Federazione Russa 13
IE - Irlanda 10
BR - Brasile 9
VN - Vietnam 8
TR - Turchia 7
FR - Francia 5
AT - Austria 2
AU - Australia 2
CZ - Repubblica Ceca 2
ID - Indonesia 2
IN - India 2
IR - Iran 2
SE - Svezia 2
AR - Argentina 1
CO - Colombia 1
EC - Ecuador 1
GE - Georgia 1
HU - Ungheria 1
JO - Giordania 1
JP - Giappone 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.110
Città #
Warsaw 196
Fairfield 48
Jacksonville 45
Woodbridge 40
Ann Arbor 38
Houston 33
Singapore 32
Ashburn 31
Seattle 31
Wilmington 27
Chandler 25
Madrid 23
Hong Kong 22
Cambridge 17
Princeton 17
Nanjing 16
Beijing 15
Brescia 14
Helsinki 14
New York 14
Los Angeles 13
Dublin 10
Dong Ket 8
Lancaster 7
Istanbul 6
Jinan 6
Shenyang 6
Changsha 5
Dearborn 5
Boardman 4
Des Moines 4
Hebei 4
Nanchang 4
The Dalles 4
San Mateo 3
Ardabil 2
Haikou 2
Jakarta 2
Jiaxing 2
Lanzhou 2
Milan 2
Monmouth Junction 2
Phoenix 2
San Diego 2
Shanghai 2
Tianjin 2
Verona 2
Almaty 1
Amman 1
Belo Horizonte 1
Bratislava 1
Brno 1
Buenos Aires 1
Campinas 1
Canberra 1
Changchun 1
Chisinau 1
Hangzhou 1
Itanhaém 1
Joinville 1
Kilburn 1
Kunming 1
Leawood 1
Manaus 1
Moscow 1
Newark 1
Ningbo 1
Nuremberg 1
Nürnberg 1
Olomouc 1
Orange 1
Quito 1
Riga 1
San Francisco 1
Segovia 1
Southwark 1
Sydney 1
São Caetano do Sul 1
São Paulo 1
Taiyuan 1
Timóteo 1
Tokyo 1
Uberlândia 1
Vienna 1
Wandsworth 1
Washington 1
Zhengzhou 1
Totale 851
Nome #
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 234
Role of the soluble pattern recognition receptor PTX3 in vascular biology. 210
Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist. 168
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 142
Role of inflammation in FGF2-driven angiogenesis 94
FGF2-binding peptides and uses thereof 80
FGF2-Antagonist activity of long pentraxin-3 related peptides 72
FGF2- Antagonist activity of long pentraxin-3 72
FGF2-binding peptides and uses therof 65
Totale 1.137
Categoria #
all - tutte 4.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.183


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202028 0 0 0 0 0 0 0 0 0 0 12 16
2020/2021163 5 19 5 26 5 15 9 17 25 7 20 10
2021/202275 0 18 0 0 0 3 2 4 3 16 5 24
2022/202378 10 4 7 3 3 15 0 5 12 1 7 11
2023/2024124 8 22 14 6 7 16 5 5 17 10 1 13
2024/2025123 1 1 0 26 21 14 6 11 26 7 10 0
Totale 1.137